Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|February 12, 1998
Effects of task strain, social conflict, and emotional activation on ambulatory cardiovascular activity: daily life consequences of recurring stress in a multiethnic adult sampleT W Kamarck, S M Shiffman, L Smithline, et al.
Clinical Transplantation|September 4, 2004
Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting listR A Fisher, D Maluf, A H Cotterell, et al.
Archives of General Psychiatry|February 1, 1975
Physiological and psychological effects of methadone in manE R Gritz, S M Shiffman, M E Jarvik, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 5, 2003
Non-resective ablation and liver transplantation in patients with cirrhosis and hepatocellular carcinoma (HCC): safety and efficacyD Maluf, R A Fisher, T Maroney, et al.
Lancet (London, England)|October 5, 2001
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialM P Manns, J G McHutchison, S C Gordon, et al.
Hepatology (Baltimore, Md.)|March 30, 1999
A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis CS Zeuzem, U Hopf, V Carreno, et al.
The American Journal of Gastroenterology|November 30, 2000
A multicenter, randomized trial of daily high-dose interferon-alfa 2b for the treatment of chronic hepatitis c: pretreatment stratification by viral burden and genotypeM W Fried, M Shiffman, R K Sterling, et al.
Hepatology (Baltimore, Md.)|February 15, 2001
Efficacy and safety of pegylated (40-kd) interferon alpha-2a compared with interferon alpha-2a in noncirrhotic patients with chronic hepatitis CK R Reddy, T L Wright, P J Pockros, et al.
Pageof 2